pteridines has been researched along with Long QT Syndrome in 1 studies
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Volasertib is a selective cell cycle kinase inhibitor that induces mitotic arrest and apoptosis by targeting Polo-like kinase (Plk)." | 1.48 | Strategic and Statistical Considerations on the QT Assessment of Volasertib. ( Fritsch, H; Taube, T; Wallenstein, G; Walter, B, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wallenstein, G | 1 |
| Walter, B | 1 |
| Fritsch, H | 1 |
| Taube, T | 1 |
1 other study available for pteridines and Long QT Syndrome
| Article | Year |
|---|---|
Strategic and Statistical Considerations on the QT Assessment of Volasertib.
Topics: Clinical Trials as Topic; Drugs, Investigational; Electrocardiography; Humans; Long QT Syndrome; Pro | 2018 |